Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / micronucleus study
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
publication
Title:
In vitro genotoxicity of Melaleuca alternifolia essential oil in human lymphocytes
Author:
Pereira T. S., Rocha de Sant'Anna J, Silva E. L., Pinheiro A. L., Alves de Castro-Prado M. A.
Year:
2014
Bibliographic source:
Journal of Ethnopharmacology 151 (2014) 852–857
Report date:
2013

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
Deviations:
yes
Remarks:
no metabolic activation used
GLP compliance:
not specified
Type of assay:
in vitro mammalian cell micronucleus test

Test material

Constituent 1
Reference substance name:
Melaleuca Alternifolia /Tea Tree) Leaf oil
Cas Number:
68647-73-4
IUPAC Name:
Melaleuca Alternifolia /Tea Tree) Leaf oil

Method

Species / strain
Species / strain / cell type:
lymphocytes: human
Details on mammalian cell type (if applicable):
CELLS USED
- Sex, age and number of blood donors: Male (2), female (1), aged 25 years
Test concentrations with justification for top dose:
95, 182, and 365 µg/ml
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
mitomycin C
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Preincubation period: 24 h
- Exposure duration: 20 h
- Blockage of cytokinesis: At 44 h (with cytochalasin B)
- Incubation time, total: 72 h

ACTIN FILAMENT INHIBITOR: cytochalasin B (final concentration 6 µg/ml)

STAIN: 5% Giemsa (pH 6.8)

NUMBER OF REPLICATIONS: 3

NUMBER OF CELLS EVALUATED: 1000 each (a total of 3000 cells per concentration)

DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
- Any supplementary information relevant to cytotoxicity: Mitotic index was calculated by the number of dividing cells/total number of the cells x 100

Evaluation criteria:
The cytokinesis block proliferation index (CBPI) was determined as follows: CBPI=N1+2N2+3(N3+N4)/500, where N1–N4 are the cells with one to four nuclei in 500 cells counted for each experiment.
The amount of cytostasis was determined as follows: % cytostasis=100-100 [(CBPI(T)-1)/(CBPI(C)-1)], where CBPI(T) was the CBPI rate of treatment and CBPI(C) was the CBPI rate of negative control.
Statistics:
Data were expressed as frequencies of micronuclei and mean +/- standard deviation (SD) of the mean for buds and CBPI rates. Results were statistically analyzed by Z-test and the non-parametric Kruskal–Wallis test (p<0.05).

Results and discussion

Test results
Species / strain:
lymphocytes: human
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 365 µg/ml
Untreated negative controls validity:
valid
Positive controls validity:
valid

Any other information on results incl. tables

The chemical composition of the tea tree oil was determined and the main constituent was observed to be terpinen-4 -ol with 42.8%.

Applicant's summary and conclusion

Conclusions:
Tea tree oil was tested negative under the conditions chosen in this micronucleus assay and thus, was considered to be non-mutagenic.
Executive summary:

The genotoxic potential of tea tree oil was investigated by the in vitro chromosome aberration assay using human lymphocytes derived from donors. Subjects were non-smoking, non-alcoholic, not under drug therapy and without recent history of exposure to mutagens. Human lymphocytes were treated with three concentrations ( 95, 182, and 365 µg/m) in triplicate. None of the concentrations caused a significant increase in the observed frequencies of micronuclei when compared to the negative control. The positive control mytomicin C induced a significant response. Cytotoxicity was observed at 365 µg/ml.